Da Volterra's DAV132 Shown As Promising Candidate for Preventing Severe C. Difficile Infections

Product News   May 13, 2014

 
Da Volterra's DAV132 Shown As Promising Candidate for Preventing Severe C. Difficile Infections
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Benefits of Droplet Digital PCR to Measure Immunotherapy Response Highlighted at ASCO Annual Meeting

Product News

New research demonstrating the clinical potential of Droplet Digital PCR technology to measure patient response to immunotherapy was presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in June.

READ MORE

Owlstone Medical, Cancer Research UK Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease

Product News

Owlstone Medical and Cancer Research UK begin trial to improve the speed of detection and diagnosis of multiple cancer types.

READ MORE

Arcinova Use FlowSyn for Efficient Scale-Up of Challenging Batch Processes

Product News

Arcinova has invested in a FlowSyn™ continuous flow reactor enabling them to develop and simplify the scale-up of a challenging API batch process.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE